129 related articles for article (PubMed ID: 26232936)
1. The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells.
Segerer SE; Bartmann C; Kaspar S; Müller N; Kapp M; Butt E; Kämmerer U
Arch Gynecol Obstet; 2016 Feb; 293(2):407-14. PubMed ID: 26232936
[TBL] [Abstract][Full Text] [Related]
2. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract][Full Text] [Related]
3. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
4. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
[TBL] [Abstract][Full Text] [Related]
5. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Wang H; Li W; Jin X; Cui S; Zhao L
Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
[TBL] [Abstract][Full Text] [Related]
6. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
Zheng J; Wang F; Lu S; Wang X
Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
[TBL] [Abstract][Full Text] [Related]
7. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract][Full Text] [Related]
8. [Impact of LASP-1 expression on proliferation and tumorigenesis of human colorectal cancer cell line SW480].
Zhao L; Ding YQ
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):830-4. PubMed ID: 21215099
[TBL] [Abstract][Full Text] [Related]
9. IMP1 promotes choriocarcinoma cell migration and invasion through the novel effectors RSK2 and PPME1.
Hsieh YT; Chou MM; Chen HC; Tseng JJ
Gynecol Oncol; 2013 Oct; 131(1):182-90. PubMed ID: 23911878
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.
Grunewald TG; Kammerer U; Winkler C; Schindler D; Sickmann A; Honig A; Butt E
Br J Cancer; 2007 Jan; 96(2):296-305. PubMed ID: 17211471
[TBL] [Abstract][Full Text] [Related]
11. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
Gao W; Han J
Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
[TBL] [Abstract][Full Text] [Related]
12. Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells.
Tang R; Kong F; Hu L; You H; Zhang P; Du W; Zheng K
Virol J; 2012 Aug; 9():163. PubMed ID: 22897902
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer.
Shimizu F; Shiiba M; Ogawara K; Kimura R; Minakawa Y; Baba T; Yokota S; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e83187. PubMed ID: 24386158
[TBL] [Abstract][Full Text] [Related]
14. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
[TBL] [Abstract][Full Text] [Related]
15. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
Duvall-Noelle N; Karwandyar A; Richmond A; Raman D
Oncogene; 2016 Mar; 35(9):1122-33. PubMed ID: 25982273
[TBL] [Abstract][Full Text] [Related]
16. Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
Shi J; Guo J; Li X
Int J Oncol; 2018 Jan; 52(1):179-188. PubMed ID: 29138807
[TBL] [Abstract][Full Text] [Related]
17. Investigating lasp-2 in cell adhesion: new binding partners and roles in motility.
Bliss KT; Chu M; Jones-Weinert CM; Gregorio CC
Mol Biol Cell; 2013 Apr; 24(7):995-1006. PubMed ID: 23389630
[TBL] [Abstract][Full Text] [Related]
18. Differential display RT-PCR analysis of human choriocarcinoma cell lines and normal term trophoblast cells: identification of new genes expressed in placenta.
García J; Castrillo JL
Placenta; 2004; 25(8-9):684-93. PubMed ID: 15450385
[TBL] [Abstract][Full Text] [Related]
19. LASP-1, a novel urinary marker for detection of bladder cancer.
Ardelt P; Grünemay N; Strehl A; Jilg C; Miernik A; Kneitz B; Butt E
Urol Oncol; 2013 Nov; 31(8):1591-8. PubMed ID: 22481019
[TBL] [Abstract][Full Text] [Related]
20. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
